Literature DB >> 14975549

Vascular endothelial growth factor: the link between cardiovascular risk factors and microalbuminuria?

F W Asselbergs1, R A de Boer, G F H Diercks, B Langeveld, R A Tio, P E de Jong, D J van Veldhuisen, W H van Gilst.   

Abstract

BACKGROUND: Microalbuminuria, i.e. slightly elevated urinary albumin excretion, is associated with increased cardiovascular risk factors and cardiovascular morbidity in the general population. Microalbuminuria has been proposed to indicate increased endothelial permeability. Unknown are the mechanisms underlying this increased vascular permeability. Vascular endothelial growth factor (VEGF), also known as vascular permeability factor, increases endothelial permeability. We hypothesised that plasma VEGF levels may be associated with microalbuminuria in a large sample of the general population.
METHODS: Out of a large sample of the general population, we studied 189 control subjects (urinary albumin excretion (UAE): 0-30 mg/24 h) and 194 microalbuminuric subjects (UAE: 30-300 mg/24 h), matched for age, sex and the presence of ischemia on the electrocardiogram.
RESULTS: Subjects with microalbuminuria had significant higher plasma levels of VEGF (p<0.05). The correlation between plasma levels of VEGF and systolic and diastolic blood pressure, cholesterol, glucose, diabetes and body mass index were statistically significant. Using logistic regression analysis, microalbuminuria was significantly associated with VEGF (odds ratio 1.62; 95% confidence interval: 1.15-2.27; p<0.01). This association was dependent on cardiovascular risk factors.
CONCLUSION: This study suggests a relation between increased plasma VEGF levels and subsequent occurrence of microalbuminuria.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14975549     DOI: 10.1016/j.ijcard.2003.04.001

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  7 in total

1.  Relationship of Albuminuria and Renal Artery Stent Outcomes: Results From the CORAL Randomized Clinical Trial (Cardiovascular Outcomes With Renal Artery Lesions).

Authors:  Timothy P Murphy; Christopher J Cooper; Karol M Pencina; Ralph D'Agostino; Joseph Massaro; Donald E Cutlip; Kenneth Jamerson; Alan H Matsumoto; William Henrich; Joseph I Shapiro; Katherine R Tuttle; David J Cohen; Michael Steffes; Qi Gao; D Christopher Metzger; William B Abernethy; Stephen C Textor; John Briguglio; Alan T Hirsch; Sheldon Tobe; Lance D Dworkin
Journal:  Hypertension       Date:  2016-09-19       Impact factor: 10.190

2.  The role of cystatin C and the angiogenic cytokines VEGF and bFGF in patients with esophageal carcinoma.

Authors:  Martin Dreilich; Gunnar Wagenius; Stefan Bergström; Daniel Brattström; Anders Larsson; Patrik Hesselius; Michael Bergqvist
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

3.  Association between gamma-glutamyltransferase and albuminuria in nondiabetic adults with normal renal function.

Authors:  Sun-Hye Ko; Myong Ki Baeg; Kyung-Do Han; Seung-Yeon Ko; Sae-Bom Shin; Seung-Hyun Ko; Yu-Bae Ahn
Journal:  Clin Exp Nephrol       Date:  2016-12-09       Impact factor: 2.801

4.  Prevalence of and factors associated with albuminuria in the Korean adult population: the 2011 Korea National Health and Nutrition Examination Survey.

Authors:  Jong Chul Won; Yun Jeong Lee; Jung Min Kim; Sang Youb Han; Jung Hyun Noh; Kyung Soo Ko; Byoung Doo Rhee; Dong-Jun Kim
Journal:  PLoS One       Date:  2013-12-27       Impact factor: 3.240

5.  The ratio of AGE to sRAGE independently associated with albuminuria in hypertensive patients.

Authors:  Kuang-Hsing Chiang; Jaw-Wen Chen; Shao-Sung Huang; Hsin-Bang Leu; Shing-Jong Lin; Po-Hsun Huang
Journal:  BMC Endocr Disord       Date:  2018-11-13       Impact factor: 2.763

6.  The relationship of endothelial function and arterial stiffness with subclinical target organ damage in essential hypertension.

Authors:  Yancui Sun; Fei Liu; Ying Zhang; Yan Lu; Zhuolin Su; Haizhe Ji; Yunpeng Cheng; Wei Song; Tesfaldet H Hidru; Xiaolei Yang; Yinong Jiang
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-03-03       Impact factor: 3.738

7.  VEGF levels in plasma in relation to platelet activation, glycemic control, and microvascular complications in type 1 diabetes.

Authors:  Reinier O Schlingemann; Cornelis J F Van Noorden; Mattheus J M Diekman; Anna Tiller; Joost C M Meijers; Pieter Koolwijk; Wilmar M Wiersinga
Journal:  Diabetes Care       Date:  2013-01-15       Impact factor: 19.112

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.